SHANGHAI, China--(BUSINESS WIRE)--GeneScience Pharmaceuticals Co., Ltd. (GenSci) announced today that the company’s new drug, Genfulin™, a topical gel indicated for the treatment of wound healing, is expected to get approval by China’s SFDA in early 2007.
